Position in SNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$34,301,028
-$16,987,352 QoQ
Shares Held
804,056
-24.5% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#41
of 712 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAUSEWAY CAPITAL MANAGEMENT LLC holds $2,118,676,056 across 8 Drug Manufacturers - General names. SNY ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
9,357,390 | $1,774,348,291 | |
| 2 | MRK |
Merck & Co., Inc.
|
954,932 | $122,708,762 | |
| 3 | NVO |
Novo Nordisk A S
|
1,677,615 | $80,424,863 | |
| 4 | BIIB |
Biogen Inc.
|
278,283 | $60,125,824 | |
| 5 | PFE |
Pfizer Inc
|
1,916,801 | $46,156,568 | |
| 6 | SNY |
Sanofi
This page
|
804,056 | $34,301,028 | |
| 7 | GSK |
GSK plc
|
7,163 | $375,484 | |
| 8 | NVS |
Novartis AG
|
1,501 | $235,236 |
All Filings in SNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,301,028 | 804,056 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $51,288,380 | 1,064,516 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $51,559,404 | 1,063,958 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $46,223,762 | 979,317 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $40,562,960 | 839,639 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $38,448,255 | 693,261 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $33,299,728 | 690,436 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $28,669,887 | 497,482 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $23,360,681 | 481,465 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $22,641,719 | 465,879 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $21,994,037 | 442,269 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $25,781,636 | 480,642 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $20,054,465 | 372,068 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $18,634,387 | 342,418 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $19,587,852 | 404,457 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $17,643,827 | 464,067 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $24,848,950 | 496,681 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $31,326,795 | 610,183 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $32,029,180 | 639,305 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $30,662,331 | 636,016 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $36,166,730 | 686,797 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $31,404,923 | 634,956 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $21,845,383 | 449,586 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $16,290,600 | 324,708 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $8,897,249 | 174,285 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||